Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/recognition-of-shared-melanoma-antigen-by-hla-a2-restricted-cytolytic-IgfgZPyQCt
References (27)
-
T. Springer, Michael Dustin, T. Kishimoto, S. Marlin (1987)
The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system.Annual review of immunology, 5
-
B. Koller, H. Orr (1985)
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.Journal of immunology, 134 4
-
A. Anichini, R. Mortarini, R. Supino, G. Parmiani (1990)
Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive abilityInternational Journal of Cancer, 46
-
T. Darrow, C. Slingluff, H. Seigler (1989)
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.Journal of immunology, 142 9
-
R. Salter, R. Benjamin, P. Wesley, S. Buxton, T. Garrett, C. Clayberger, A. Krensky, A. Norment, D. Littman, P. Parham (1990)
A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2Nature, 345
-
P. vanderBruggen, C. Traversari, P. Chomez, C. Lurquin, E. DePlaen, Van Bj, A. Knuth, T. Boon (1991)
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science, 254 5038
-
P. Ennis, J. Zemmour, Russell Salter, Peter Parham (1990)
Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification.Proceedings of the National Academy of Sciences of the United States of America, 87 7
-
Kiyoshi Ishii, Takashi Tsuruo, Noriaki Ohuchi, Cheryl Szpak, William Johnston, D. Wynford-Thomas, Michael Samson, John Young, Laurence Baker, A. DonaldJ., Sutherland, Damien Thomson, Wendy Shelley, E. Robert, Myers, Betty Mobbs, Donald Kufe, E. Douglas, Merkel, Jane Winter, Walter Hauck, Bame Carter, Gross, Daniel Beck, Miguel Munoz, J. Benfield, R. Paladugu, Norio Azumi, Hyun Pak, Raymond, L. Teplitz, Kikuchi, T. Tanimoto, Kozo Kaibuchi, Y. Takai, Alfonso d'Orazio, Gino Coletti, Tilden, Charles Balch, Alison, McCurdy (1986)
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.Cancer research, 46 6
-
E. Kemenade, A. Velde, A. Boer, R. Weening, A. Fischer, J. Borst, C. Melief, C. Figdor (1992)
Both LFA‐1‐positive and ‐deficient T cell clones require the CD2/LFA‐3 interaction for specific cytolytic activationEuropean Journal of Immunology, 22
-
J. Sambrook, E. Fritsch, T. Maniatis (2001)
Molecular Cloning: A Laboratory Manual -
K. Itoh, C. Platsoucas, C. Balch (1988)
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptorThe Journal of Experimental Medicine, 168
-
M. Pandolfino, C. Viret, N. Gervois, Y. Guilloux, F. Davodeau, E. Diéz, F. Jotereau (1992)
Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma‐infiltrating lymphocytesEuropean Journal of Immunology, 22
-
B. Dupont, R. Ceppellini (1989)
Immunobiology of HLA -
E. Braakman, P. Goedegebuure, R. Vreugdenhil, D. Segal, S. Shaw, R. Bolhuis (1990)
Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysisInternational Journal of Cancer, 46
-
N. Crowley, T. Darrow, M. Quinn-Allen, H. Seigler (1991)
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.Journal of immunology, 146 5
-
A. Castaño, P. Lauzurica, N. Domenech, J. Castro (1991)
Structural identity between HLA-A2 antigens differentially recognized by alloreactive cytotoxic T lymphocytes.Journal of immunology, 146 9
-
P. Bjorkman, P. Bjorkman, P. Bjorkman, M. Saper, B. Samraoui, W. Bennett, W. Bennett, J. Strominger, D. Wiley (1987)
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigensNature, 329
-
S. Powis, Deverson Ev, Coadwell Wj, A. Ciruela, A. Ciruela, Huskisson Ns, H. Smith, G. Butcher, Jonathan Howard (1992)
Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I moleculeNature, 357
-
T. Wölfel, E. Klehmann, C. Müller, K. Schütt, K.-H. Büschenfelde, A. Knuth (1989)
Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigensThe Journal of Experimental Medicine, 170
-
N. Gervois, F. Heuźe, E. Diéz, F. Jotereau (1990)
Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangementsEuropean Journal of Immunology, 20
-
S. Horn, S. Topalian, T. Simonis, M. Mancini, S. Rosenberg (1991)
Common Expression of Melanoma Tumor-Associated Antigens Recognized by Human Tumor Infiltrating Lymphocytes: Analysis by Human Lymphocyte Antigen RestrictionJournal of Immunotherapy, 10
-
J. Castro (1989)
HLA-B27 and HLA-A2 subtypes: structure, evolution and functionImmunology Today, 10
-
Yutaka Kawakami, Rina Zakut, S. Topalian, Hans Stötter, S. Rosenberg (1992)
Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.Journal of immunology, 148 2
-
(1991)
De Plaen. -
(1989)
Darr0w -
J. Zemmour, P. Parham (1991)
HLA class I nucleotide sequences, 1991.Human immunology, 31 3
-
(1992)
Viret, C., Gervois, N.,
- Publisher
- Wiley
- Copyright
- Copyright © 1993 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
- ISSN
- 0014-2980
- eISSN
- 1521-4141
- DOI
- 10.1002/eji.1830230123
- pmid
- 8419164
- Publisher site
- See Article on Publisher Site
Abstract
Three melanoma‐specific cytotoxic T lymphocytes (CTL) clones were derived from the tumor‐infiltrating lymphocyte (TIL) of human melanoma M17, and were used to study the expression of immunogenic melanoma peptides on allogeneic tumors. Antibody inhibition studies showed that two of these TIL clones were restricted by an HLA‐A2 molecule which was identified as A2.1 by gene sequencing. The third CTL clone was not restricted by HLA‐A2, but by a B or C HLA antigen. HLA‐A2‐restricted CTL clones M17‐1 and M17‐2 lysed 5 and 12 out of 15 HLA‐A2+ allogeneic melanomas, respectively. Since they did not lyse autologous Epstein‐Barr virus B cells, HLA‐A2.1‐transfected P815 cells,13 HLA‐A2+ non‐melanoma tumor cell lines and 10 HLA‐A2− melanomas, these clones appeared specific for melanoma‐restricted epitopes presented by the HLA‐A2.1 molecule. We then tried to determine why a few HLA‐A2+ melanomas were refractory to TIL lysis. By using a combination of flow cytometry analysis, partial cloning and sequencing of their HLA‐A2 genes, we show that failure to lyse did not result from low expression or polymoprhism of the HLA‐A2 molecule, or from deficient expression of the adhesion molecules ICAM‐1 and LFA‐3 by these melanomas. Taken together, our data confirm at the clonal level the existence of shared melanoma antigens recognized by TIL in the HLA‐A2.1 context. They further show that individual peptides derived from these antigens are expressed by a large majority of HLA‐A2+ melanomas. Identification of such peptides appears crucial for the future of vaccination therapies.
Journal
European Journal of Immunology – Wiley
Published: Jan 1, 1993